Evolocumab
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Evolocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $2.0 billion on Evolocumab across 2.2 million claims for 460,000 beneficiaries.
Evolocumab is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $281.81 to $281.96 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$281.81 – $281.96
per ML
7d Activity
avg +0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amgen Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
PCSK9 Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing EVOLOCUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REPATHA 140 MG/ML SURECLICK | $281.9611 per ML | 0.00% |
REPATHA 140 MG/ML SURECLICK | $281.9611 per ML | 0.00% |
REPATHA 140 MG/ML SYRINGE | $281.8058 per ML | — |
REPATHA 140 MG/ML SYRINGE | $281.8058 per ML | — |
Frequently Asked Questions
What is Evolocumab used to treat?
Evolocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Evolocumab?
In 2024, Medicare Part D spent $2.0 billion on Evolocumab across 2.2 million claims for 460,000 beneficiaries.
How many Evolocumab products are on the market?
The Evolocumab drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Evolocumab?
NADAC reference prices for Evolocumab range from $281.8058 to $281.9611 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Evolocumab?
1 manufacturer lists Evolocumab in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (4).
How has the price of Evolocumab changed recently?
Over the past 7 days, 0 Evolocumab NDCs rose and 0 fell, with a market-wide average change of +0.0%.